Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer

Mesothelin (MSLN) overexpression (OE) is a frequent finding in ovarian carcinomas and increases cell survival and tumor aggressiveness. Since cancer stem cells (CSCs) contribute to pathogenesis, chemoresistance and malignant behavior in ovarian cancer (OC), we hypothesized that MSLN expression could...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunes, Mariana, Pacheco, Francisca, Coelho, Ricardo, Leitão, Dina, Ricardo, Sara, David, Leonor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834752/
https://www.ncbi.nlm.nih.gov/pubmed/35162954
http://dx.doi.org/10.3390/ijms23031016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834752/
https://www.ncbi.nlm.nih.gov/pubmed/35162954
http://dx.doi.org/10.3390/ijms23031016

Ejemplares similares